Exosome RNA Exosome RNA Research & Industry News
Preliminary results show levels of disease-related biomarkers remain unchanged in people living with ALS who are treated with standard of care...
Read More »NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study
Coya Therapeutics Secures Option Agreement for Exclusive Worldwide Rights to Exosome Engineering Technology from Carnegie Mellon University
Coya Therapeutics announced the execution of an option agreement for exclusive worldwide rights to a novel and proprietary technology platform enabling...
Read More »Exosome Engineering Strategies for Cargo Loading and Targeting Delivery
Creative Biolabs expands exosome engineering services for wider applications, especially for loading cargo into exosomes and targeting delivery. Exosomes have been acknowledged as promising natural carriers for drug loading and delivery, mainly due to their biological characteristics of intercellular communicator ...
Read More »Coya Therapeutics Secures $10 Million Financing to Advance Clinical and Pre-Clinical Pipeline of Treg-Derived Exosome Therapeutics
Coya Therapeutics, a clinical-stage biotechnology company developing multiple first-in-class and best-in-class approaches that enhance regulatory T cell (Treg) function, today announced that it has raised approximately $10.3 million from institutional and...
Read More »Novel assay for early detection of ovarian cancer in extracellular vesicles significantly outperforms current standard test
Mercy BioAnalytics, a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that the Mercy Halo Ovarian Cancer (OC) assay substantially outperformed...
Read More »Evox Therapeutics Presents Progress Across its DeliverEX™ Exosome Therapeutics Platform
Evox Therapeutics, a leading exosome therapeutics company, announced advances in exosome engineering, manufacturing and tissue targeting at the International Society for Extracellular Vesicles (ISEV) Annual Meeting, on May 25 to 29, 2022, in Lyon...
Read More »Predicine Liquid Biopsy Outperforms Four Other Leading ctDNA NGS Tests in a Study by Bristol Myers Squibb
Predicine, a global molecular insights company, today announced the results of a new research study that demonstrated superior performance of the PredicineATLAS™ liquid biopsy next-generation...
Read More »VivaZome to collaborate with the University of Queensland traumatic brain injury experts to develop exosome-based therapies
VivaZome Therapeutics announced that it has entered into a Memorandum of Understanding (MoU) with The University of Queensland (UQ) focusing on improved therapies for Traumatic Brain Injury...
Read More »ExoCoBio Receives Japanese Patent for Alleviating Dermatitis with Adipose Stem Cell-Derived Exosome
ExoCoBio, one of global top 4 for stem cell exosome industry, announced that it received from Japanese Patent Office the patent which claims that stem cell-derived exosome is proved as effective ingredient for...
Read More »Supportive Exosome-Based Solutions for Anticancer Drug Delivery
Creative Biolabs is proud to announce supportive solutions for research that explores exosomes as effective vehicles for delivering anticancer drugs to tumors. Researchers from the University of Glasgow, Griffith University, and Yale University recently led a study on applying exosomes ...
Read More »